{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:21:40Z","timestamp":1789590100338,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejphar.2026.178683","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:15:32Z","timestamp":1771949732000},"page":"178683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["From neuropsychiatric use to oncology: Repurposing antipsychotic drugs for cancer treatment"],"prefix":"10.1016","volume":"1019","author":[{"given":"Gandhali","family":"Ghaisas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3718-9858","authenticated-orcid":false,"given":"Vaishali Y.","family":"Londhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178683_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1693805","article-title":"The dual role of glycogen synthase Kinase-3 Beta (GSK3\u03b2) in neurodegenerative pathologies: interplay between autophagy disease progression","volume":"16","author":"Alhassan","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178683_bib2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/cancers14030776","article-title":"Dissecting the mechanism of action of Spiperone\u2014 A candidate for drug repurposing for colorectal cancer","volume":"14","author":"Antona","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178683_bib3","first-page":"651","article-title":"New drugs are not enough-drug repositioning in oncology: an update","volume":"56","author":"Armando","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"24","key":"10.1016\/j.ejphar.2026.178683_bib4","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.3390\/cancers14246047","article-title":"An evaluation of the anticancer properties of SYA014, a homopiperazine-oxime analog of Haloperidol in triple negative breast cancer cells","volume":"14","author":"Asong","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178683_bib5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.drudis.2018.01.018","article-title":"A bibliometric review of drug repurposing","volume":"23","author":"Baker","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2026.178683_bib6","first-page":"243","article-title":"5-HT serotonin receptors modulate mitogenic signaling and impact tumor cell viability","author":"Ballou","year":"2018","journal-title":"Mol. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-89627-0","article-title":"Drug repurposing for ligand-induced rearrangement of Sirt2 active site-based inhibitors via molecular modeling and quantum mechanics calculations","volume":"11","author":"Bharadwaj","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1592\/phco.29.1.64","article-title":"Antipsychotic-induced hyperprolactinemia","volume":"29","author":"Bostwick","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2026.178683_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104809","article-title":"Treatment of cancer with antipsychotic medications: pushing the boundaries of schizophrenia and cancer","volume":"141","author":"Brown","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.ejphar.2026.178683_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178683_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12061560","article-title":"New use for old drugs: the protective effect of risperidone on colorectal cancer","volume":"12","author":"Chen","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2026.178683_bib12","article-title":"Association of risperidone with gastric cancer: triangulation method from cell study, animal study, and cohort study","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"13","key":"10.1016\/j.ejphar.2026.178683_bib13","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.3390\/cancers14133089","article-title":"Haloperidol instigates endometrial carcinogenesis and cancer progression by the NF-\u03baB\/CSF-1 signaling cascade","volume":"14","author":"Chiang","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.ejphar.2026.178683_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ajg.2013.407","article-title":"How drugs are developed and approved by the FDA: current process and future directions","volume":"109","author":"Ciociola","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2026.178683_bib15","series-title":"Study of Fluphenazine in Relapsed or relapsed-and-refractory Multiple Myeloma (Clinicaltrials.Gov Identifier: NCT00821301)","year":"2013"},{"key":"10.1016\/j.ejphar.2026.178683_bib16","series-title":"Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer: a Pilot, Randomized, Open Label, Controlled Study (NCT05433402)","year":"2022"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178683_bib17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1176\/appi.focus.20160009","article-title":"Schizophrenia pharmacology: past, present, and future targets for intervention","volume":"14","author":"Cronenwett","year":"2016","journal-title":"Focus"},{"key":"10.1016\/j.ejphar.2026.178683_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.665832","article-title":"Chlorpromazine sensitizes progestin-resistant endometrial cancer cells to MPA by upregulating PRB","volume":"11","author":"Cui","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178683_bib19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/15384047.2020.1726718","article-title":"Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer","volume":"21","author":"Dees","year":"2020","journal-title":"Cancer Biol. Ther."},{"issue":"7","key":"10.1016\/j.ejphar.2026.178683_bib20","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.7150\/ijbs.32625","article-title":"The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer","volume":"15","author":"Dong","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178683_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.52965\/001c.38930","article-title":"Phenothiazines and their evolving roles in clinical practice: a narrative review","volume":"10","author":"Edinoff","year":"2022","journal-title":"Health Psychol. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178683_bib22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s10517-024-06191-z","article-title":"Anticancer effects of spiperone in C57BL\/6 mice with emphysema and lung carcinoma","volume":"177","author":"Ermakova","year":"2024","journal-title":"Bull. Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib23","first-page":"1","article-title":"Penfluridol overcomes paclitaxel resistance in metastatic breast cancer","volume":"9","author":"Gupta","year":"2019","journal-title":"Sci. Rep. 2019"},{"issue":"12","key":"10.1016\/j.ejphar.2026.178683_bib24","article-title":"Trehalose and carnosic acid induced LC3I, LC3II ratio, P62 down-regulation and cleaved caspase 3 expression in neural stem cells","volume":"123","author":"Haghdoost-Yazdi","year":"2022","journal-title":"Bratislava Med. J. Bratislavsk\u00e9 Lek\u00e1rske Listy"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178683_bib25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/neuonc\/noaa188","article-title":"Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors","volume":"23","author":"He","year":"2021","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1158\/1535-7163.MCT-16-0451","article-title":"Penfluridol represses integrin expression in breast cancer through induction of reactive oxygen species and downregulation of Sp transcription factors","volume":"16","author":"Hedrick","year":"2017","journal-title":"Mol. Cancer Therapeut."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178683_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101012","article-title":"Phenothiazines alter plasma membrane properties and sensitize cancer cells to injury by inhibiting annexin-mediated repair","volume":"297","author":"Heitmann","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178683_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.05.031","article-title":"Molecular mechanisms of anti-psychotic drugs for improvement of cancer treatment","volume":"856","author":"Hendouei","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejphar.2026.178683_bib29","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3390\/cancers11121869","article-title":"Dissecting the anticancer mechanism of trifluoperazine on pancreatic ductal adenocarcinoma","volume":"11","author":"Huang","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ejphar.2026.178683_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.989","article-title":"Aripiprazole sensitizes head and neck cancer cells to ionizing radiation by enhancing the production of reactive oxygen species","volume":"10","author":"Jeong","year":"2022","journal-title":"Pharmacol. Res. Perspect."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178683_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051046","article-title":"Trifluoperazine and its analog suppressed the tumorigenicity of non-small cell lung cancer cell; applicability of antipsychotic drugs to lung cancer treatment","volume":"10","author":"Jeong","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2026.178683_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114403","article-title":"Chlorpromazine, an antipsychotic agent, induces G2\/M phase arrest and apoptosis via regulation of the PI3K\/AKT\/mTOR-mediated autophagy pathways in human oral cancer","volume":"184","author":"Jhou","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2024.2302413","article-title":"The antipsychotic drug pimozide promotes apoptosis through the RAF\/ERK pathway and enhances autophagy in breast cancer cells","volume":"25","author":"Jiang","year":"2024","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-018-0969-z","article-title":"Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions","volume":"20","author":"Johnston","year":"2018","journal-title":"Breast Cancer Res."},{"issue":"14","key":"10.1016\/j.ejphar.2026.178683_bib35","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.18632\/oncotarget.28010","article-title":"Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment","volume":"12","author":"Kamgar-Dayhoff","year":"2021","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.ejphar.2026.178683_bib36","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10495-012-0717-2","article-title":"Thioridazine induces apoptosis by targeting the PI3K\/Akt\/mTOR pathway in cervical and endometrial cancer cells","volume":"17","author":"Kang","year":"2012","journal-title":"Apoptosis : Int. J. Programmed Cell Death"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/1535-7163.MCT-16-0169-T","article-title":"Trifluoperazine, a well-known antipsychotic, inhibits glioblastoma invasion by binding to calmodulin and disinhibiting calcium release channel IP3R","volume":"16","author":"Kang","year":"2017","journal-title":"Mol. Cancer Therapeut."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11060-014-1688-7","article-title":"Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect","volume":"122","author":"Karpel-Massler","year":"2015","journal-title":"J. Neuro-oncol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neo.2017.10.002","article-title":"Role of dopamine receptors in the anticancer activity of ONC201","volume":"20","author":"Kline","year":"2018","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.ejphar.2026.178683_bib40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4196\/kjpp.2020.24.6.441","article-title":"Trends in the development of human stem cell-based non-animal drug testing models","volume":"24","author":"Lee","year":"2020","journal-title":"Korean J. Physiol. Pharmacol.: Off. J. Korean Physiol. Soc. Korean Soc. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178683_bib41","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.21873\/invivo.12054","article-title":"ERK\/AKT inactivation and apoptosis induction associate with quetiapine-inhibited cell survival and invasion in hepatocellular carcinoma cells","volume":"34","author":"Lee","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.ejphar.2026.178683_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.phrs.2016.05.004","article-title":"A cell-based quantitative high-throughput image screening identified novel autophagy modulators","volume":"110","author":"Li","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2026.178683_bib43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.schres.2017.08.065","article-title":"The incidence rate of cancer in patients with schizophrenia: a meta-analysis of cohort studies","volume":"195","author":"Li","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2026.178683_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113063","article-title":"Pimozide inhibits the growth of breast cancer cells by alleviating the Warburg effect through the P53 signaling pathway","volume":"150","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178683_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14737140.2022.1987221","article-title":"Repurposing antipsychotic drugs for cancer treatment: current evidence and future perspectives","volume":"22","author":"Lianos","year":"2022","journal-title":"Expet Rev. Anticancer Ther."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178683_bib46","article-title":"Patient-derived xenograft models: current status, challenges, and innovations in cancer research","volume":"12","author":"Liu","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.ejphar.2026.178683_bib47","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1016\/j.wneu.2019.04.180","article-title":"Synergistic suppression of glioblastoma cell growth by combined application of temozolomide and dopamine D2 receptor antagonists","volume":"128","author":"Liu","year":"2019","journal-title":"World Neurosurg."},{"issue":"17","key":"10.1016\/j.ejphar.2026.178683_bib48","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.3390\/cancers13174357","article-title":"Paliperidone inhibits glioblastoma growth in mouse brain tumor model and reduces PD-L1 expression","volume":"13","author":"Liu","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.ejphar.2026.178683_bib49","first-page":"856","article-title":"Repurposing drugs for solid tumor treatment: focus on immune checkpoint inhibitors","volume":"20","author":"Liu","year":"2023","journal-title":"Cancer Biol. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178683_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268635","article-title":"Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cells","volume":"17","author":"Manoharan","year":"2022","journal-title":"PLoS One"},{"issue":"February","key":"10.1016\/j.ejphar.2026.178683_bib51","first-page":"1","article-title":"Anticancer properties of the antipsychotic drug chlorpromazine and its synergism with temozolomide in restraining human glioblastoma proliferation in vitro","volume":"11","author":"Matteoni","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2026.178683_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1320621","article-title":"Repurposing phenothiazines for cancer therapy: compromising membrane integrity in cancer cells","volume":"13","author":"Mehrabi","year":"2023","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178683_bib53","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3892\/or.2014.3068","article-title":"Thioridazine, an antipsychotic drug, elicits potent antitumor effects in gastric cancer","volume":"31","author":"Mu","year":"2014","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178683_bib54","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3390\/biomedicines12061134","article-title":"Iloperidone and temozolomide synergistically inhibit growth, migration and enhance apoptosis in glioblastoma cells","volume":"12","author":"Mubeen","year":"2024","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178683_bib55","article-title":"Application of organoids in translational research of human diseases with a particular focus on gastrointestinal cancers","volume":"1873","author":"Nguyen","year":"2020","journal-title":"Biochimica et Biophys. Acta (BBA)-Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib56","first-page":"28","article-title":"Computational and practical aspects of drug repositioning","volume":"1","author":"Oprea","year":"2015","journal-title":"Drug Repurpos. Rescue. Reposition."},{"issue":"12","key":"10.1016\/j.ejphar.2026.178683_bib57","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3390\/biomedicines8120595","article-title":"Haloperidol induced cell cycle arrest and apoptosis in glioblastoma cells","volume":"8","author":"Papadopoulos","year":"2020","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.ejphar.2026.178683_bib58","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.21873\/anticanres.16084","article-title":"COX-2 acts as a key mediator of trifluoperazine-induced cell death in U87MG glioma cells","volume":"42","author":"Park","year":"2022","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2026.178683_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/srep26165","article-title":"Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis","volume":"6","author":"Ranjan","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178683_bib61","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1158\/0008-5472.CAN-15-1233","article-title":"Penfluridol: an antipsychotic agent suppresses metastatic tumor growth in triple-negative breast cancer by inhibiting integrin signaling axis","volume":"76","author":"Ranjan","year":"2016","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178683_bib62","first-page":"74","article-title":"Molecular mechanisms of antipsychotics\u2013their influence on intracellular signaling pathways, and epigenetic and post-transcription processes","volume":"31","author":"Rok-Bujko","year":"2022","journal-title":"Adv. Psychiatry Neurol. Postepy Psychiatrii i Neurologii"},{"key":"10.1016\/j.ejphar.2026.178683_bib63","first-page":"1","article-title":"Drug Repurposing (DR): an emerging approach in drug discovery","author":"Rudrapal","year":"2020","journal-title":"Drug Repurpos. Hypothesis Mol. Aspects Therap. Appl."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43789-1","article-title":"In-silico and in-vitro study reveals ziprasidone as a potential aromatase inhibitor against breast carcinoma","volume":"13","author":"Sahu","year":"2023","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ejphar.2026.178683_bib65","first-page":"6177","article-title":"Olanzapine, an atypical antipsychotic, inhibits survivin expression and sensitizes cancer cells to chemotherapeutic agents","volume":"37","author":"Sanomachi","year":"2017","journal-title":"Anticancer Res."},{"issue":"8","key":"10.1016\/j.ejphar.2026.178683_bib66","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00210-020-01918-x","article-title":"A simple mechanistic terminology of psychoactive drugs: a proposal","volume":"393","author":"Seifert","year":"2020","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ejphar.2026.178683_bib67","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fonc.2013.00313","article-title":"Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development","volume":"3","author":"Stenvang","year":"2013","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.ejphar.2026.178683_bib68","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.21873\/anticanres.15237","article-title":"Lurasidone sensitizes cancer cells to osimertinib by inducing autophagy and reduction of survivin","volume":"41","author":"Suzuki","year":"2021","journal-title":"Anticancer Res."},{"issue":"8","key":"10.1016\/j.ejphar.2026.178683_bib69","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1292\/jvms.15-0707","article-title":"Anti-tumor effects of perphenazine on canine lymphoma","volume":"78","author":"Tsuji","year":"2016","journal-title":"J. Vet. Med. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178683_bib70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3892\/ol.2020.12374","article-title":"Perphenazine exerts antitumor effects on HUT78 cells through Akt dephosphorylation by protein phosphatase 2A","volume":"21","author":"Tsuji","year":"2021","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178683_bib71","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/ijnpnd.IJNPND_82_21","article-title":"Antiproliferative effects of olanzapine against MCF-7 cells and its molecular interactions with survivin","volume":"12","author":"Varahi Vedam","year":"2022","journal-title":"Int. J. Nutrit. Pharmacol. Neurol. Dis."},{"key":"10.1016\/j.ejphar.2026.178683_bib72","author":"Varga"},{"issue":"12","key":"10.1016\/j.ejphar.2026.178683_bib73","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3390\/cancers12123636","article-title":"Patient-derived tumor organoids for drug repositioning in cancer care: a promising approach in the era of tailored treatment","volume":"12","author":"Vivarelli","year":"2020","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.ejphar.2026.178683_bib74","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.3390\/biomedicines9121785","article-title":"Repurposing antipsychotics for cancer treatment","volume":"9","author":"Vlachos","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib75","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1124\/jpet.119.256818","article-title":"Cancer and the dopamine D2 receptor: a pharmacological perspective","volume":"370","author":"Weissenrieder","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178683_bib76","series-title":"Latest Global Cancer Data: Cancer Burden Rises to 19.3 Million New Cases and 10.0 Million Cancer Deaths in 2020","year":"2020"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib77","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12929-019-0557-2","article-title":"Penfluridol triggers cytoprotective autophagy and cellular apoptosis through ROS induction and activation of the PP2A-modulated MAPK pathway in acute myeloid leukemia with different FLT3 statuses","volume":"26","author":"Wu","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejphar.2026.178683_bib78","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3389\/fphar.2019.01029","article-title":"Antipsychotic drug trifluoperazine suppresses colorectal cancer by inducing G0\/G1 arrest and apoptosis","volume":"10","author":"Xia","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib79","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13045-018-0662-9","article-title":"Organoid technology and applications in cancer research","volume":"11","author":"Xu","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178683_bib80","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1159\/000369751","article-title":"Clozapine induces autophagic cell death in non-small cell lung cancer cells","volume":"35","author":"Yin","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178683_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/srep13249","article-title":"Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells","volume":"5","author":"Yoshino","year":"2015","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ejphar.2026.178683_bib82","article-title":"Chemosensitization by phenothiazines in human lung cancer cells: impaired resolution of \u03b3H2AX and increased oxidative stress elicit apoptosis associated with lysosomal expansion and intense vacuolation","volume":"2","author":"Zong","year":"2011","journal-title":"Cell Death Disease 2011"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926001652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926001652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:57:29Z","timestamp":1779425849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926001652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":82,"alternative-id":["S0014299926001652"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178683","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From neuropsychiatric use to oncology: Repurposing antipsychotic drugs for cancer treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178683"}}